In individuals with T2DM, IL-6 infusion can also improve glucose tolerance, potentially via augmented GLP-1-mediated insulin secretion or delayed gastric emptying, though these effects do not necessarily indicate direct muscle–adipose metabolic crosstalk [189]. This evidence concerns the gene INS and type 2 diabetes mellitus.